left
  Scientific Committee on Emerging and Newly Identified Health Risksslide
right
transtrans
 

Mandate

It shall provide opinions on questions concerning emerging or newly identified health and environmental risks and on broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk assessment bodies.

Examples of potential areas of activity include potential risks associated with interaction of risk factors, synergic effects, cumulative effects, antimicrobial resistance, new technologies such as nanotechnologies, medical devices including those incorporating substances of animal and/or human origin, tissue engineering, blood products, fertility reduction, cancer of endocrine organs, physical hazards such as noise and electromagnetic fields (from mobile phones, transmitters and electronically controlled home environments), and methodologies for assessing new risks. It may also be invited to address risks related to public health determinants and non-transmissible diseases.

arrow Stakeholder dialogue procedure
arrow Rules of procedurespdf
arrow Members Scientific Committees (CVs and Declarations)
arrow Agenda Plenary Meetings
arrow Minutes Plenary Meetings
arrow Members Working Groups (Declarations)
arrow Minutes + Agenda Working Groups
arrow Questions
arrow Opinions
arrow Statements

See also:

arrow Former Scientific Committees

Contact

Katja BROMEN


European Commission
Health & Consumer Protection DG
Directorate C: Public Health and Risk Assessment
Unit C7: Risk Assessment
Office: B232, 2/106
B-1049 Brussels
Tel (+32-2-29)85552
Fax: (+32-2-29)57332
E-mail: Sanco-Sc1-Secretariat@ec.europa.eu

 
lefttranspright

 

  printable version  
Public HealthFood SafetyConsumer Affairs
   
   
   
   
requires javascript